References
- Ahmad A, Aboukameel A, Kong D, et al (2011). Phosphoglucose isomerase/autocrine motility factor mediates epithelialmesenchymal transition regulated by miR-200 in breast cancer cells. Cancer Res, 71, 3400-9. https://doi.org/10.1158/0008-5472.CAN-10-0965
- Anaya-Ruiz M, Bandala C, Perez-Santos JL (2013). MiR-485 acts as a tumor suppressor by inhibiting cell growth and migration in breast carcinoma T47D cells. Asian Pac J Cancer Prev, 14, 3757-60. https://doi.org/10.7314/APJCP.2013.14.6.3757
- Anaya-Ruiz M, Cebada J, Delgado-Lopez G, et al (2013). MiR-153 silencing induces apoptosis in the MDA-MB-231 breast cancer cell line. Asian Pac J Cancer Prev, 14, 2983-6. https://doi.org/10.7314/APJCP.2013.14.5.2983
- Bienertova-Vasku J, Sana J, Slaby O (2013). The role of microRNAs in mitochondria in cancer. Cancer Lett, 336, 1-7. https://doi.org/10.1016/j.canlet.2013.05.001
- Calin GA, Cimmino A, Fabbri M, et al (2008). MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA, 105, 5166-71. https://doi.org/10.1073/pnas.0800121105
- Chen YH, Heneidi S, Lee JM, et al (2013). MiRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Diabetes, 62, 2278-86. https://doi.org/10.2337/db12-0963
- Chow TF, Mankaruos M, Scorilas A, et al (2010). The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. J Urol, 183, 743-51. https://doi.org/10.1016/j.juro.2009.09.086
- Croce CM (2009). Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet, 10, 704-14. https://doi.org/10.1038/nrg2634
- Das S, Ferlito M, Kent OA, et al(2012). Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res, 110, 1596-603. https://doi.org/10.1161/CIRCRESAHA.112.267732
- Ebi H, Sato T, Sugito N, et al (2009). Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers. Oncogene, 28, 3371-9. https://doi.org/10.1038/onc.2009.201
- Eichner LJ, Perry MC, Dufour CR, et al (2010). MiR-378(*) mediates metabolic shift in breast cancer cells via the PGC-1beta/ERRgamma transcriptional pathway. Cell Metab, 12, 352-61. https://doi.org/10.1016/j.cmet.2010.09.002
- Fang R, Xiao T, Fang Z, et al (2012). MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene. J Biol Chem, 287, 23227-35. https://doi.org/10.1074/jbc.M112.373084
- Fei X, Qi M, Wu B, et al (2012). MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression. FEBS Lett, 586, 392-7. https://doi.org/10.1016/j.febslet.2012.01.006
- Gao P, Tchernyshyov I, Chang TC, et al (2009). c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature, 458, 762-5. https://doi.org/10.1038/nature07823
- Garzon R, Calin GA, Croce CM (2009). MicroRNAs in Cancer. Annu Rev Med, 60, 167-79. https://doi.org/10.1146/annurev.med.59.053006.104707
- Gatenby RA, Gillies RJ (2004). Why do cancers have high aerobic glycolysis? Nat Rev Cancer, 4, 891-9. https://doi.org/10.1038/nrc1478
- Gigli I, Maizon DO (2013). MicroRNAs and the mammary gland: A new understanding of gene expression. Genet Mol Biol, 36, 465-74. https://doi.org/10.1590/S1415-47572013005000040
- Hatziapostolou M, Polytarchou C, Iliopoulos D(2013). miRNAs link metabolic reprogramming to oncogenesis. Trends Endocrinol Metab, 24, 361-73. https://doi.org/10.1016/j.tem.2013.03.002
- Horie T, Ono K, Nishi H, et al (2009). MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes. Biochem Biophys Res Commun, 389, 315-20. https://doi.org/10.1016/j.bbrc.2009.08.136
- Hsu PP, Sabatini DM (2008). Cancer cell metabolism: Warburg and beyond. Cell, 134, 703-7. https://doi.org/10.1016/j.cell.2008.08.021
- Ichimi T, Enokida H, Okuno Y, et al (2009). Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer Suppl, 125, 345-52. https://doi.org/10.1002/ijc.24390
- Iorio MV, Croce CM (2012). MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med, 4, 143-59. https://doi.org/10.1002/emmm.201100209
- Jackson AL, Bartz SR, Schelter J, et al (2003). Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol, 21, 635-7. https://doi.org/10.1038/nbt831
- Jiang S, Zhang LF, Zhang HW, et al (2012). A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells. EMBO J, 31, 1985-98. https://doi.org/10.1038/emboj.2012.45
- Kefas B, Comeau, L, Erdle N, et al (2010). Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells. Neuro Oncol, 12, 1102-12. https://doi.org/10.1093/neuonc/noq080
- Kinoshita T, Nohata N, Yoshino H, et al (2012). Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma. Int J Oncol, 40, 185-93.
- Latronico MV, Condorelli G (2012). The might of microRNA in mitochondria. Circ Res, 110, 1540-2. https://doi.org/10.1161/CIRCRESAHA.112.271312
- Li J, Donath S, Li Y, et al (2010). MiR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS Genet, 6, e1000795. https://doi.org/10.1371/journal.pgen.1000795
- Li J, Xu ZW, Wang KH, et al (2013). Networks of MicroRNAs and genes in retinoblastomas. APJCP, 14, 6631-6.
- Li P, Jiao J, Gao G,et al (2012). Control of mitochondrial activity by miRNAs. J Cell Biochem, 113, 1104-10. https://doi.org/10.1002/jcb.24004
- Li SZ, Hu YY, Zhao J, et al (2014). MicroRNA-34a induces apoptosis in the human glioma cell line, A172, through enhanced ROS production and NOX2 expression. Biochem Biophys Res Commun, 444, 6-12. https://doi.org/10.1016/j.bbrc.2013.12.136
- Li W, Wang J, Chen QD, et al (2013). Insulin promotes glucose consumption via regulation of miR-99a/mTOR/PKM2 pathway. PloS one, 8, e64924. https://doi.org/10.1371/journal.pone.0064924
- Lu H. Buchan RJ, Cook SA (2010). MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc Res, 86, 410-20. https://doi.org/10.1093/cvr/cvq010
- Lunt SY, Vander Heiden MG (2011). Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol, 27, 441-4. https://doi.org/10.1146/annurev-cellbio-092910-154237
- Macheda ML, Rogers S, Best JD (2005). Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol, 202, 654-62. https://doi.org/10.1002/jcp.20166
- Ma L, Weinberg RA (2008). Micromanagers of malignancy: role of microRNAs in regulating metastasis.Trends Genet, 24, 448-56. https://doi.org/10.1016/j.tig.2008.06.004
- Mateescu B, Batista L, Cardon M, et al (2011). MiR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med, 17, 1627-35. https://doi.org/10.1038/nm.2512
- Pullen TJ, Silva Xavier G, Kelsey G, et al(2011). MiR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol Cell Biol, 31, 3182-94. https://doi.org/10.1128/MCB.01433-10
- Qi B , Yao WJ, Zhao BS, et al (2003). Involvement of microRNA-198 overexpression in the poor prognosis of esophageal cancer. APJCP, 14, 5073-6.
- Rengaraj D, Park TS, Lee SI, et al (2013). Regulation of glucose phosphate isomerase by the 3'UTR-specific miRNAs miR-302b and miR-17-5p in chicken primordial germ cells. Biol Reprod, 89, 33. https://doi.org/10.1095/biolreprod.112.105692
- Rottiers V, Naar AM (2012). MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol, 13, 239-50. https://doi.org/10.1038/nrm3313
- Shea CM, Tzertzinis G (2010). Controlled expression of functional miR-122 with a ligand inducible expression system. BMC Biotechnol, 10, 76. https://doi.org/10.1186/1472-6750-10-76
- Shi Q, Gibson GE (2011). Up-regulation of the mitochondrial malate dehydrogenase by oxidative stress is mediated by miR-743a. J Neurochem, 118, 440-8. https://doi.org/10.1111/j.1471-4159.2011.07333.x
- Sikand K, Singh J, Ebron JS, et al (2012). Housekeeping gene selection advisory: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and beta-actin are targets of miR-644a. PloS one, 7, e47510. https://doi.org/10.1371/journal.pone.0047510
- Singh PK, Brand RE, Mehla K (2012). MicroRNAs in pancreatic cancer metabolism. Nat Rev Gastroenterol Hepatol, 9, 334-44. https://doi.org/10.1038/nrgastro.2012.63
- Srivastava SK, Bhardwaj A, Singh S, et al (2011). MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis, 32, 1832-9. https://doi.org/10.1093/carcin/bgr223
- Sun Q, Chen X, Ma J, et al (2011). Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc Natl Acad Sci USA, 108, 4129-34. https://doi.org/10.1073/pnas.1014769108
- Sun Y, Zhao X, Zhou Y, et al (2012). MiR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect. Oncol Rep, 28, 1346-52.
- Tanaka H, Sasayama T, Tanaka K, et al (2013). MicroRNA-183 upregulates HIF-1alpha by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells. J Neurooncol, 111, 273-83. https://doi.org/10.1007/s11060-012-1027-9
- Tomasetti M, Neuzil J, Dong L (2014). MicroRNAs as regulators of mitochondrial function: role in cancer suppression. Biochim Biophys Acta, 1840, 1441-53. https://doi.org/10.1016/j.bbagen.2013.09.002
- Trajkovski M, Hausser J, Soutschek J, et al (2011). MicroRNAs 103 and 107 regulate insulin sensitivity. Nature, 474, 649-53. https://doi.org/10.1038/nature10112
- Venkataraman S, Alimova I, Fan R, et al (2010). MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence. PloS one, 5, e10748. https://doi.org/10.1371/journal.pone.0010748
- Vohwinkel CU, Lecuona E, Sun H, et al (2011). Elevated CO(2) levels cause mitochondrial dysfunction and impair cell proliferation. J Biol Chem, 286, 37067-76. https://doi.org/10.1074/jbc.M111.290056
- Volinia S, Croce CM (2013). Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proc Natl Acad Sci U S A, 110, 7413-7. https://doi.org/10.1073/pnas.1304977110
- Wang JX, Jiao JQ, Li Q, et al (2011). MiR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med, 17, 71-8. https://doi.org/10.1038/nm.2282
- Wang K, Long B, Jiao JQ, et al (2012). MiR-484 regulates mitochondrial network through targeting Fis1. Nat Commun, 3, 781. https://doi.org/10.1038/ncomms1770
- Wilfred BR, Wang WX, Nelson PT (2007). Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab, 91, 209-17. https://doi.org/10.1016/j.ymgme.2007.03.011
- Wise DR, DeBerardinis RJ, Mancuso A, et al (2008). Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA, 105, 18782-7. https://doi.org/10.1073/pnas.0810199105
- Wong TS, Liu XB., Chung-Wai HoA, et al (2008). Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer Suppl, 123, 251-7. https://doi.org/10.1002/ijc.23583
- Yamasaki T, Seki N, Yoshino H, et al (2013). Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma. Cancer Sci, 104, 1411-9. https://doi.org/10.1111/cas.12240
- You JS, Jones PA (2012). Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell, 22, 9-20 https://doi.org/10.1016/j.ccr.2012.06.008
- Zhang X, Ng W L, Wang P, et al (2012). MicroRNA-21 modulates the levels of reactive oxygen species by targeting SOD3 and TNFalpha. Cancer Res, 72, 4707-13. https://doi.org/10.1158/0008-5472.CAN-12-0639
- Zhao H, Guan J, Lee HM, et al (2010). Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition. Pancreas, 39, 843-6. https://doi.org/10.1097/MPA.0b013e3181d12613
- Zhou Q, Souba WW, Croce CM, et al (2010). MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut, 59, 775-84. https://doi.org/10.1136/gut.2009.181834
Cited by
- 2-deoxy-D-Glucose Synergizes with Doxorubicin or L-Buthionine Sulfoximine to Reduce Adhesion and Migration of Breast Cancer Cells vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3213
- Expression Levels of Warburg-Effect Related microRNAs Correlate with each Other and that of Histone Deacetylase Enzymes in Adult Hematological Malignancies with Emphasis on Acute Myeloid Leukemia vol.23, pp.1, 2017, https://doi.org/10.1007/s12253-016-0151-9
- Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells vol.8, pp.2, 2017, https://doi.org/10.1038/cddis.2017.35
- Long non-coding RNAs in cancer metabolism vol.38, pp.10, 2016, https://doi.org/10.1002/bies.201600110